ChatGPT in Clinical Medicine, Urology and Academia: A Review.

ChatGPT artificial intelligence machine learning neural network urology

Journal

Archivos espanoles de urologia
ISSN: 0004-0614
Titre abrégé: Arch Esp Urol
Pays: Spain
ID NLM: 0064757

Informations de publication

Date de publication:
Aug 2024
Historique:
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 6 9 2024
Statut: ppublish

Résumé

This study aims to provide a comprehensive overview of the current literature on the utilisation of ChatGPT in the fields of clinical medicine, urology, and academic medicine, while also addressing the associated ethical challenges and potential risks. This narrative review conducted an extensive search of the PubMed and MEDLINE databases, covering the period from January 2022 to January 2024. The search phrases employed were "urologic surgery" in conjunction with "artificial intelligence", "machine learning", "neural network", "ChatGPT", "urology", and "medicine". The initial studies were chosen from the screened research to examine the possible interaction between those entities. Research utilising animal models was excluded. ChatGPT has demonstrated its usefulness in clinical settings by producing precise clinical correspondence, discharge summaries, and medical records, thereby assisting in these laborious tasks, especially with the latest iterations of ChatGPT. Furthermore, patients can access essential medical information by inquiring with ChatGPT. Nevertheless, there are multiple concerns regarding the correctness of the system, including allegations of falsified data and references. These issues emphasise the importance of having a doctor oversee the final result to guarantee patient safety. ChatGPT shows potential in academic medicine for generating drafts and organising datasets. However, the presence of guidelines and plagiarism-detection technologies is necessary to mitigate the risks of plagiarism and the use of faked data when using it for academic purposes. ChatGPT should be utilised as a supplementary tool by urologists and academicians. However, it is now advisable to have human oversight to guarantee patient safety, uphold academic integrity, and maintain transparency.

Sections du résumé

BACKGROUND BACKGROUND
This study aims to provide a comprehensive overview of the current literature on the utilisation of ChatGPT in the fields of clinical medicine, urology, and academic medicine, while also addressing the associated ethical challenges and potential risks.
METHODS METHODS
This narrative review conducted an extensive search of the PubMed and MEDLINE databases, covering the period from January 2022 to January 2024. The search phrases employed were "urologic surgery" in conjunction with "artificial intelligence", "machine learning", "neural network", "ChatGPT", "urology", and "medicine". The initial studies were chosen from the screened research to examine the possible interaction between those entities. Research utilising animal models was excluded.
RESULTS RESULTS
ChatGPT has demonstrated its usefulness in clinical settings by producing precise clinical correspondence, discharge summaries, and medical records, thereby assisting in these laborious tasks, especially with the latest iterations of ChatGPT. Furthermore, patients can access essential medical information by inquiring with ChatGPT. Nevertheless, there are multiple concerns regarding the correctness of the system, including allegations of falsified data and references. These issues emphasise the importance of having a doctor oversee the final result to guarantee patient safety. ChatGPT shows potential in academic medicine for generating drafts and organising datasets. However, the presence of guidelines and plagiarism-detection technologies is necessary to mitigate the risks of plagiarism and the use of faked data when using it for academic purposes.
CONCLUSIONS CONCLUSIONS
ChatGPT should be utilised as a supplementary tool by urologists and academicians. However, it is now advisable to have human oversight to guarantee patient safety, uphold academic integrity, and maintain transparency.

Identifiants

pubmed: 39238293
pii: 1724985504271-953166207
doi: 10.56434/j.arch.esp.urol.20247707.99
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

708-717

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Lazaros Tzelves (L)

Department of Urology, University College of London Hospitals (UCLH), W1G8PH London, UK.
2nd Department of Urology, Sismanoglio Hospital, National and Kapodistrian University of Athens, 10431 Athens, Greece.
EAU Young Academic Urologists (YAU) Endourology and Urolithiasis Working Group, NL-6803 Arnhem, Netherlands.

Konstantinos Kapriniotis (K)

Department of Urology, University College of London Hospitals (UCLH), W1G8PH London, UK.

Georgios Feretzakis (G)

Department of Quality Control, Research and Continuing Education, Sismanogleio General Hospital, 15124 Marousi, Greece.

Stamatios Katsimperis (S)

2nd Department of Urology, Sismanoglio Hospital, National and Kapodistrian University of Athens, 10431 Athens, Greece.

Ioannis Manolitsis (I)

2nd Department of Urology, Sismanoglio Hospital, National and Kapodistrian University of Athens, 10431 Athens, Greece.

Patrick Juliebø-Jones (P)

EAU Young Academic Urologists (YAU) Endourology and Urolithiasis Working Group, NL-6803 Arnhem, Netherlands.
Department of Urology, Haukeland University Hospital, 5003 Bergen, Norway.
Department of Clinical Medicine, University of Bergen, 5003 Bergen, Norway.

Amelia Pietropaolo (A)

EAU Young Academic Urologists (YAU) Endourology and Urolithiasis Working Group, NL-6803 Arnhem, Netherlands.
Department of Urology, University Hospital Southampton, SO16 Southampton, UK.

Senol Tonyali (S)

EAU Young Academic Urologists (YAU) Endourology and Urolithiasis Working Group, NL-6803 Arnhem, Netherlands.
Department of Urology, Istanbul University Istanbul Faculty of Medicine, 34000 Istanbul, Turkey.

Themistoklis Bellos (T)

2nd Department of Urology, Sismanoglio Hospital, National and Kapodistrian University of Athens, 10431 Athens, Greece.

Bhaskar Somani (B)

Department of Urology, University Hospital Southampton, SO16 Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH